메뉴 건너뛰기




Volumn 31, Issue 24, 2010, Pages 2974-2976

Genetic variability in response to clopidogrel therapy: Clinical implications

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; CYTOCHROME P450 2C19; CYTOCHROME P450 ISOENZYME; MULTIDRUG RESISTANCE PROTEIN 1; PRASUGREL; PURINERGIC P2Y12 RECEPTOR; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CYP2C19 PROTEIN, HUMAN; CYP2C9 PROTEIN, HUMAN; CYTOCHROME P450 2C9; TICLOPIDINE; UNSPECIFIC MONOOXYGENASE;

EID: 78650317150     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq329     Document Type: Review
Times cited : (24)

References (15)
  • 1
    • 60749114799 scopus 로고    scopus 로고
    • Interindividual variability in the response to oral antiplatelet drugs; A position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
    • Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R. Interindividual variability in the response to oral antiplatelet drugs; a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2009;30: 426-435.
    • (2009) Eur Heart J , vol.30 , pp. 426-435
    • Kuliczkowski, W.1    Witkowski, A.2    Polonski, L.3    Watala, C.4    Filipiak, K.5    Budaj, A.6    Golanski, J.7    Sitkiewicz, D.8    Pregowski, J.9    Gorski, J.10    Zembala, M.11    Opolski, G.12    Huber, K.13    Arnesen, H.14    Kristensen, S.D.15    De Caterina, R.16
  • 2
    • 74249104162 scopus 로고    scopus 로고
    • Clopidogrel response status assessed with multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting
    • Sibbing D, Morath T, Braun S, Stegherr J. Clopidogrel response status assessed with multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 2010;103:151-159.
    • (2010) Thromb Haemost , vol.103 , pp. 151-159
    • Sibbing, D.1    Morath, T.2    Braun, S.3    Stegherr, J.4
  • 6
    • 77955082077 scopus 로고    scopus 로고
    • Genetic variation in metabolizing enzyme and transporter genes: Comprehensive assessment in 3 major East asian subpopulations with comparison to Caucasians and Africans
    • Man M, Farmen M, Dumaual C, Teng C, Moser B, Irie S, Noh G, Njau R, Close S, Wise S, Hockett R. Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East asian subpopulations with comparison to Caucasians and Africans. J Clin Pharmacol 2010;50:929-940.
    • (2010) J Clin Pharmacol , vol.50 , pp. 929-940
    • Man, M.1    Farmen, M.2    Dumaual, C.3    Teng, C.4    Moser, B.5    Irie, S.6    Noh, G.7    Njau, R.8    Close, S.9    Wise, S.10    Hockett, R.11
  • 7
    • 77955425743 scopus 로고    scopus 로고
    • ACCF/AHA Clopido-grel Clinical Alert: Approaches to the FDA 'Boxed Warning' A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association
    • Holmes Dj, Dehmer G, Kaul S, Leifer D, O'Gara P, Stein C. ACCF/AHA Clopido-grel Clinical Alert: Approaches to the FDA 'Boxed Warning'. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. Circulation 2010;122: 537-557.
    • (2010) Circulation , vol.122 , pp. 537-557
    • Dj, H.1    Dehmer, G.2    Kaul, S.3    Leifer, D.4    O'Gara, P.5    Stein, C.6
  • 10
    • 67649370752 scopus 로고    scopus 로고
    • Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans
    • Lee JM, Park S, Shin DJ, Choi D, Shim CY. Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans. Am J Cardiol 2009;104:46-51.
    • (2009) Am J Cardiol , vol.104 , pp. 46-51
    • Lee, J.M.1    Park, S.2    Shin, D.J.3    Choi, D.4    Shim, C.Y.5
  • 11
    • 43049179414 scopus 로고    scopus 로고
    • Cytochrome P450 2C19 681G.A ploymorphism and high on clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
    • Trenk D, Hochholzer W, Fromm MF, Chialda LE, Pahl A, Valina CM, Stratz C, Schmiebusch P, Bestehorn HP, Buttner HJ, Neumann F. Cytochrome P450 2C19 681G.A ploymorphism and high on clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol 2008;51: 1925-1934.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1925-1934
    • Trenk, D.1    Hochholzer, W.2    Fromm, M.F.3    Chialda, L.E.4    Pahl, A.5    Valina, C.M.6    Stratz, C.7    Schmiebusch, P.8    Bestehorn, H.P.9    Buttner, H.J.10    Neumann, F.11
  • 12
    • 67649645191 scopus 로고    scopus 로고
    • Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
    • Varenhorst C, James S, Erlinge D, Brandt JT, Braun OO, Man M, Siegbahn A, Walker JR, Wallentin L, Winters KJ, Close SL. Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease. Eur Heart J 2009;30:1744-1752.
    • (2009) Eur Heart J , vol.30 , pp. 1744-1752
    • Varenhorst, C.1    James, S.2    Erlinge, D.3    Brandt, J.T.4    Braun, O.O.5    Man, M.6    Siegbahn, A.7    Walker, J.R.8    Wallentin, L.9    Winters, K.J.10    Close, S.L.11
  • 13
    • 78650326491 scopus 로고    scopus 로고
    • Cytochrome P450 genetic variants predict cardiovascular outcomes following treatment with clopidogrel but not prasugrel
    • Abstract 1439
    • Mega JL, Shen L, Wivion SD. Cytochrome P450 genetic variants predict cardiovascular outcomes following treatment with clopidogrel but not prasugrel. Circulation 2008;118:S325-S326 (Abstract 1439).
    • (2008) Circulation , vol.118
    • Mega, J.L.1    Shen, L.2    Wivion, S.D.3
  • 14
    • 77957262385 scopus 로고    scopus 로고
    • Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update
    • Cuisset T, Valgimigli M, Mudra H, Muller O, Wijns W, Huber K. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update. EuroIntervention 2010;6:39-45.
    • (2010) EuroIntervention , vol.6 , pp. 39-45
    • Cuisset, T.1    Valgimigli, M.2    Mudra, H.3    Muller, O.4    Wijns, W.5    Huber, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.